Elanco Director Purchases $936K Worth of Shares
Lawrence Erik Kurzius, a director at Elanco Animal Health (ELAN), purchased 40,000 shares for $23.40 per share on August 20, 2026, totaling $936,000 in transaction value. This purchase increased his direct holdings by 27%, bringing the total to 188,647 shares valued at approximately $4.4 million post-transaction. Elanco is a global animal health company with a market capitalization of around $11.8 billion and trailing twelve-month revenue of $5 billion as of August 20, 2026. The stock closed at $23.56 on that date. Kurzius's purchase may be interpreted by investors as a positive signal for the company’s future performance. The insider holds only direct equity in Elanco and no indirect positions. Over the past year, ELAN has outperformed the S&P 500 with a stock price increase of approximately 40% compared to an 18.7% rise in the broader index.
Tickers: $ELAN